EMEDvs its industry peers
A metric-by-metric comparison of EMED against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEDThis | — | — | — | — | 17.3%#2 | 23.9%#2 | -153.1%#2 | — | — | 4#1 | — | — |
| DAVI | $33M#4 | — | — | — | — | — | — | — | — | — | — | — |
| DRTS | $1.2B#1 | — | 15.1x#3 | — | — | -34.3%#6 | — | -55.3%#3 | -60.3%#3 | — | — | — |
| DRTSW | $276M#2 | — | 3.6x#1 | — | — | -34.3%#6 | — | -55.3%#3 | -60.3%#3 | — | — | — |
| EBRCZ | — | — | — | — | — | -19.5%#5 | -2850.2%#6 | -70.8%#5 | -89.8%#5 | — | — | — |
| ECIA | — | — | — | — | -0.5%#4 | 68.2%#1 | -2.6%#1 | -11.8%#1 | -7.9%#1 | — | — | — |
| FOFA | — | — | — | — | — | -390.4%#8 | -226.0%#3 | -49.4%#2 | -41.6%#2 | — | — | — |
| GIPL | — | — | — | — | — | -427.4%#9 | — | -135.1%#6 | -245.3%#6 | — | — | — |
| HRGN | — | — | — | — | 63.7%#1 | 11.2%#3 | -982.2%#5 | — | — | — | — | — |
| ICCM | $56M#3 | 3.2x#1 | 6.2x#2 | 16.7x#1 | 2.7%#3 | 1.7%#4 | -446.7%#4 | -166.4%#7 | -9038.3%#7 | 4#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice